Israeli cancer breakthrough ‘doubles life expectancy’
search

The latest Jewish News

Read this week’s digital edition

Click Here

Israeli cancer breakthrough ‘doubles life expectancy’

New drug developed to treat specific type of pancreatic cancer in people who carry BRCA mutation, which is more prevalent among Ashkenasi Jews than the general population

Cancer cells
Cancer cells

Israeli scientists have developed a targeted pancreatic cancer therapy for people who carry the BRCA genetic mutation .

The breakthrough will be of interest to Jewish communities around the world, because about one-in-40 people with Ashkenazi Jewish heritage have a mutation of the BRCA1 or BRCA2 gene, compared to one-in-800 of the general population.

While trials are ongoing, the new drug in question is called Lynparza (olaparib), which has been shown to treat a specific type of metastatic pancreatic cancer in people who carry the BRCA1 or BRCA2 mutation.

Leading the studies has been Dr Talia Golan, head of the Sheba Medical Center Pancreatic Cancer Center at Tel Hashomer Hospital, whose team has been working with pharmaceutical giants Astrazeneca and MSD (Merck).  She said the drug, which is taken as tablets, was an important example of a new breed of “precision medicine based on a specific genetic bio-marker,” those being BRCA1 and BRCA2  in this case.

There were almost 460,000 cases of pancreatic cancer diagnosed last year, making it the 12th most common cancer worldwide. It is also one of the most deadly – currently less than three percent of metastatic pancreatic cancer sufferers survive more than five years after diagnosis. Often there are no symptoms until it is too late, meaning early diagnosis of pancreatic cancer is difficult.  Four in every five patients are diagnosed at the metastatic stage.

This week’s Jewish News front page

The new drug was tested on patients who had already undergone chemotherapy and scientists said on Monday that the latest Phase 3 trials showed that the drug nearly doubled the amount of time a patient lived without the disease progressing.

The results were announced at the 2019 American Society of Clinical Oncology Annual Meeting in Chicago and published in The New England Journal of Medicine.

“This drug provides tremendous hope for patients who have pancreatic cancer,” said Golan, a world expert who works with British olim Dr Yaacov Richard Lawrence, a senior physician in radiation oncology. “When we saw the results were positive, it really was an exceptional and phenomenal moment.”

 

Support your Jewish community. Support your Jewish News

Thank you for helping to make Jewish News the leading source of news and opinion for the UK Jewish community. Today we're asking for your invaluable help to continue putting our community first in everything we do.

For as little as £5 a month you can help sustain the vital work we do in celebrating and standing up for Jewish life in Britain.

Jewish News holds our community together and keeps us connected. Like a synagogue, it’s where people turn to feel part of something bigger. It also proudly shows the rest of Britain the vibrancy and rich culture of modern Jewish life.

You can make a quick and easy one-off or monthly contribution of £5, £10, £20 or any other sum you’re comfortable with.

100% of your donation will help us continue celebrating our community, in all its dynamic diversity...

Engaging

Being a community platform means so much more than producing a newspaper and website. One of our proudest roles is media partnering with our invaluable charities to amplify the outstanding work they do to help us all.

Celebrating

There’s no shortage of oys in the world but Jewish News takes every opportunity to celebrate the joys too, through projects like Night of Heroes, 40 Under 40 and other compelling countdowns that make the community kvell with pride.

Pioneering

In the first collaboration between media outlets from different faiths, Jewish News worked with British Muslim TV and Church Times to produce a list of young activists leading the way on interfaith understanding.

Campaigning

Royal Mail issued a stamp honouring Holocaust hero Sir Nicholas Winton after a Jewish News campaign attracted more than 100,000 backers. Jewish Newsalso produces special editions of the paper highlighting pressing issues including mental health and Holocaust remembrance.

Easy access

In an age when news is readily accessible, Jewish News provides high-quality content free online and offline, removing any financial barriers to connecting people.

Voice of our community to wider society

The Jewish News team regularly appears on TV, radio and on the pages of the national press to comment on stories about the Jewish community. Easy access to the paper on the streets of London also means Jewish News provides an invaluable window into the community for the country at large.

We hope you agree all this is worth preserving.

read more: